Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al.

Overview

authors

Teperman, Jacob

Wampler Muskardin, Theresa
Tardif, Jean-Claude
Pillinger, Michael H

publication date

January 28, 2021

published in

Annals of the rheumatic diseases Journal

Research

keywords

COVID-19

Identity

Scopus Document Identifier

85100304317

Digital Object Identifier (DOI)

10.1136/annrheumdis-2021-219898

PubMed ID

33509798

Additional Document Info

volume

82

issue

4